Quality-of-life outcomes after total neoadjuvant short course radiotherapy, chemo-immunotherapy, and total mesorectal excision for locally advanced rectal cancer von Shamseddine, Ali, Chehade, Laudy, Kattan, Joseph Gergi, Temraz, Sally Naji, Amarin, Rula, Awabdeh, Tala, Charafeddine, Maya, Al Darazi, Monita, Turfa, Rim

Volltext

The results of 3000 Fit: A prospective study led at Saint Joseph University of Beirut von Elkaddoum, Ronaldo, Eid, Roland, Haddad, Fady, Germanos, Myrna, Mehawej, Cybel, Kourie, Hampig Raphael, Kattan, Joseph Gergi

Volltext

Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal study von Shamseddine, Ali, Machmouchi, Ahmad, Natout, Mustafa, Turfa, Rim, Kattan, Joseph Gergi, Temraz, Sally Naji, Tawil, Ayman, Elkhaldi, Mousa, Jaber, Omar, Amarin, Rula, Awabdeh, Tala, Charafeddine, Maya, Al Darazi, Monita, Hussain, Hero

Volltext

Results of NGS panel of hereditary breast and ovarian cancer in Lebanese women von Al Ajami, Joseph, Jalkh, Nadine, Moubarak, Ghadi, Eid, Roland, Haddad, Fady, Kattan, Joseph Gergi, Ghosn, Marwan, Atallah, David M., Chouery Khoury, Eliane, Kourie, Hampig Raphael

Volltext

Epidemiologic and histologic characteristics of central nervous system lesions: A 20-year experience of a single institution in Lebanon von Eid, Roland, Hage, Stephanie, Antonios, Ingrid, Moussa, Rita, Khoury, Makram, Haddad, Fady, Kourie, Hampig Raphael, Kesrouani, Carole, Ghorra, Claude, Abadjian, Gerard, Kattan, Joseph Gergi

Volltext

High immunoscore as a predictor of outcome in patients who underwent chemoimmuno-therapy in locally advanced rectal cancer: A post-hoc analysis of the correlation between immunosco... von Shamseddine, Ali, Khalifeh, Ibrahim Moustafa, Elias, Charbel, Turfa, Rim, Kattan, Joseph Gergi, Mukherji, Deborah, Temraz, Sally Naji, Alqasem, Kholoud, Amarin, Rula, Alawabdeh, Tala, Deeba, Samer, Mohamad, Issa, Daoud, Faiez, Al Masri, Mahmoud, Dabous, Ali, Hushki, Ahmad, Jaber, Omar, Charafeddine, Maya, Farhat, Lama, Tawil, Ayman

Volltext

Short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma von Shamseddine, Ali, Zeidan, Youssef, Khalifeh, Ibrahim Moustafa, Kattan, Joseph Gergi, Turfa, Rim, Mukherji, Deborah, Temraz, Sally Naji, Jamali, Faek, Shaib, Yasser Hani, Soweid, Assaad, Deeba, Samer, Kreidieh, Malek, El Husseini, Ziad zuheir, Charafeddine, Maya, Al Darazi, Monita, Geara, Fady B.

Volltext

Circumvent anxiety of patients (CAP) while receiving chemotherapy at one-day hospital von Kattan, Joseph Gergi, Daher, Alain, Assaker, Lama jaoudat, Jreige, Yolla Tanios, Aintouri, Rachide Jamil, Eid, Rouba

Volltext

EGFR mutation incidence and characteristics in non-squamous lung carcinoma in the Lebanese population von Kattan, Joseph Gergi, Haddad, Fady, Kourie, Hampig Raphael, Naderi, Samah, Rassy, Marc, El Karak, Fadi Rafic, Ghosn, Marwan, Sader-Ghorra, Claude

Volltext

First-line ribociclib plus letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-2 safety results von Janni, Wolfgang, Burris, Howard A., Blackwell, Kimberly L., Hart, Lowell L., Chan, Arlene, Nusch, Arnd, Burdaeva, Olga Nikolaevna, Alba, Emilio, Yardley, Denise A., Bachelot, Thomas Denis, Gil Gil, Miguel J., Richards, Donald A., Sparano, Joseph A., Kattan, Joseph Gergi, Bourgeois, Hugues Pierre, El Karak, Fadi Rafic, Ramaswamy, Bhuvaneswari, Sutradhar, Santosh C., Miller, Michelle Kristine, Conte, Pier Franco

Volltext

A randomized phase II trial of upfront docetaxel and vinorelbine followed by either maintenance oral vinorelbine or observation in patients with HER2-negative locally advanced (LA)... von Farhat, Fadi Sami, Ghosn, Marwan, Bitar, Nizar, Dehaini, Moussa, Chahine, Georges Y., Mourad, Cynthia, Othman, Ahmed, El-Mouhebb, Mayssam, Kattan, Joseph Gergi

Volltext

PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL) von Witzig, Thomas E., Tobinai, Kensei, Rigacci, Luigi, Lin, Tongyu, Ikeda, Takashi, Vanazzi, Anna, Hino, Masayuki, Shi, Yuankai, Mayer, Jiri, Costa, Luciano J, Bermudez, Carlos DANIEL, Zhu, Jun, Belada, David, Bouabdallah, Kamal, Kattan, Joseph Gergi, Wu, Cassandra, Fan, Jenna, Louveau, Anne-Laure, Voi, Maurizio, Cavalli, Franco

Volltext